Cognitive impairment in schizophrenia is disabling, but current treatment options remain limited. The objective of the study is to meta-analyze the efficacy and safety of adjunctive antidepressants for cognitive impairment in schizophrenia.

READ FULL ARTICLE Curated publisher From www.schres-journal.com